biomarker 957 words KG: MICROGLIALACTIVATIONBIOMARKERPANEL 2026-03-31
kind:biomarkersection:biomarkersstate:publishedtopic:alzheimerstopic:parkinsonsevidence:strong
Contents

Microglial Activation Biomarker Panel for Neurodegenerative Diseases

🔬 Protein Info
Gene SymbolMICROGLIALACTIVATIONBIOMARKERPANEL
Function TREM2 is expressed on microglia and controls microglial proliferation, migration, and phagocytosis. The soluble form (sTREM2) reflects TREM2 processing and microglial activation
GeneCHI3L1
LocationAstrocytes, microglia
CSF levels50-150 ng/mL
Elevation patternAD > controls
SpecificityAstrocyte activation
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (20)

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53

Related Analyses (23)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Related Experiments (9)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40